Public Policy Letters, Statements, Legal Briefs, & Other Responses
-
ACMG Responds to FDA’s Approval for DTC Testing for Three BRCA Gene Mutations
-
ACMG Letter Regarding South Carolina House Bill 3751 (2017) – Requesting Amendments
-
ACMG Letter Regarding South Carolina Senate Bill 264 (2017) – Requesting Amendments
-
ACMG Response to Expansion of Direct-to-Consumer Genetic Testing
-
ACMG Letter to Congress Supporting the Accurate Education for Prenatal Screenings Act (HR 3441)
-
ACMG Applauds Supreme Court Decision on Gene Patents
-
ACMG Joins Amicus Brief in Mayo v. Prometheus to Counter Patents on Observations of Natural Phenomena
-
ACMG Comments to NIH about Development of the Genetic Test Registry
-
ACMG Letter Regarding California Assembly Bill 2300 (2010)
-
ACMG Comments to SACGHS on Patenting and Licensing Practices